Moderna Therapeutics

Business • Health Care
EU orders up to 300 million more vaccine doses from Moderna
EU orders up to 300 million more vaccine doses from Moderna
Credit: Illustration: Pendect, Ashley Winkler. (Creative Commons Attribution ShareAlike 4.0)

The EU has secured 300 million additional doses of Corona vaccine from the manufacturer Moderna. A second supply contract to this effect has been approved with the US company, said EU Commission President Ursula von der Leyen. According to the company, an initial 150 million of these doses would be delivered in the third and fourth quarters of 2021. There is also an option for a further 150 million cans for 2022.

Last year, the EU Commission initially ordered 160 million vaccine doses from Moderna.

Regional News • Europe
European Medicines Agency recommends authorization of Moderna Covid-19 vaccine
European Medicines Agency recommends authorization of Moderna Covid-19 vaccine
Credit: Illustration: Pendect, Ashley Winkler. (Creative Commons Attribution ShareAlike 4.0)

On Wednesday, the European Parliament Committee on Environment, Public Health and Food Safety announced on Twitter that they are "expected to follow the European Medicines Agency (EMA) recommendation and grant the authorization shortly after which the roll-out of the vaccine in the EU can begin."

Emer Cooke, EMA executive director, said on Wednesday that "this vaccine provides us with another tool to overcome the current emergency." and "It is a testament to the efforts and commitment of all involved that we have this second positive vaccine recommendation just short of a year since the pandemic was declared by WHO," she said.

Regional News • Europe
Switzerland: Country signs deal with Moderna for Coronavirus vaccine
Switzerland: Country signs deal with Moderna for Coronavirus vaccine
Credit: Photo: Mykenzie Johnson; Image Manipulation: Pendect

The Swiss government signed a deal with Moderna for early access to 4.5 million doses of a Coronavirus vaccine. It is expected that two doses will be needed for every person, therefore the Moderna deal could cover up to one quarter of the Swiss population. The country is in talks with several other vaccine companies.

Health
First COVID-19 vaccine tested

According to Associated Press the first COVID-19 vaccine was tested at the Kaiser Permanente research facility in Seattle, Washington. The vaccine was developed by the biotechnology company Moderna Therapeutics and contains a harmless part of the COVID-19 viral genome. The NHS-funded trial was fast-tracked, skipping animal experiments. According to the researchers, results may take many months.